Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Dabrafenib plus trametinib in patients with BRAFV600-muta... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
0
Authors
Michael Davies
20 more
Michael Davies
•
Philippe Saïag
18 more
•
Georgina Long
Published
June 4, 2017
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Molecular Biology
Show all topics
DOI
10.1016/s1470-2045(17)30429-1
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
The Lancet Oncology
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Molecular Biology
Show all topics
DOI
10.1016/s1470-2045(17)30429-1
Other Formats
PDF
